Douglas Pharmaceuticals Ltd.

About Douglas Pharmaceuticals Ltd.

Douglas Pharmaceuticals is New Zealand’s largest privately owned pharmaceutical and healthcare company, founded in 1967. We have an impressive track record in developing and supplying pharmaceutical products to over 40 countries across a range of therapeutic areas including dermatology, CNS, gastroenterology and oncology.  We also deliver highly personalised softgel CDMO solutions. Our ...

  • NZ
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Contact info
  • Central Park Drive and Te Pai Place Henderson, Henderson, 0610, Lincoln, Auckland 8, New Zealand

Products from Douglas Pharmaceuticals Ltd. (3)

  • Acitretin 10mg & 25mg capsules

    Product Acitretin 10mg & 25mg capsules

    Acitretin is a second-generation retinoid, taken orally and is typically used in the treatment of severe resistant psoriasis. It is a metabolite of etretinate, which was used prior to the introduction of acitretin. Etretinate was discontinued because it had a narrow therapeutic index as well...
  • Alitretinoin 10mg & 30mg softgel capsules

    Product Alitretinoin 10mg & 30mg softgel capsules

    Alitretinoin is a first-generation retinoid and a form of vitamin A. Oral consumption for the treatment of severe chronic hand eczema in adults with proven unresponsiveness to potent topical corticosteroids, oral immunosuppressants and phototherapy. 
  • Bexarotene 75mg softgel capsules

    Product Bexarotene 75mg softgel capsules

    Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent used for the treatment of cutaneous T Cell Lymphoma (CTCL). It is third-generation retinoid

Douglas Pharmaceuticals Ltd. Resources (1)